Economist Uwe Reinhardt, a corporate director to a cross section of healthcare companies, was named last week as an adviser to a privately held healthcare information technology business.
Reinhardt, 69, an economics professor at Princeton University who is widely known in healthcare policy circles, was tapped by Philadelphia-based Hx Technologies to join its advisory board. The appointment is the latest of many that leave Reinhardt straddling the occasionally conflicting worlds of corporate interests and U.S. healthcare policy.
New Jersey officials in October put Reinhardt at the head of a commission to examine the states hospital supply and oversight of public funds, one of many occasions in which he has been sought by public officials for counsel. He sits on the boards of not-for-profit Duke University Health System, Durham, N.C., and Duke University.
He also serves as a paid director for Amerigroup Corp., a Medicaid managed-care plan; devicemaker Boston Scientific Corp.; investment funds H&Q Healthcare Investors and H&Q Life Sciences Investors; and Triad Hospitals, a for-profit hospital chain facing a $6.8 billion acquisition by Community Health Systems.